Iht Wealth Management, LLC Verona Pharma PLC Transaction History

Iht Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.91 - $7.08 $72,569 - $131,404	-18,560 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.72 - $9.09 $743 - $1,181	-130 Reduced 0.7%	18,560 $121,000
Q1 2021 May 18, 2021	BUY	$7.08 - $9.33 $920 - $1,212	130 Added 0.7%	18,690 $156,000
Q4 2020 Feb 17, 2021	SELL	$5.51 - $8.11 $17,632 - $25,952	-3,200 Reduced 14.71%	18,560 $130,000
Q1 2020 May 13, 2020	BUY	$2.16 - $7.28 $2,808 - $9,464	1,300 Added 6.35%	21,760 $90,000
Q3 2019 Nov 15, 2019	BUY	$4.03 - $5.44 $12,613 - $17,027	3,130 Added 18.06%	20,460 $94,000
Q1 2019 May 16, 2019	BUY	$5.52 - $10.0 $95,661 - $173,300	17,330 New	17,330 $113,000

166

68.7M

704K

685K

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $2.17B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.